EKF Diagnostics (LON:EKF) Stock Crosses Above Two Hundred Day Moving Average - Here's Why

Key Points

• EKF Diagnostics Holdings plc's share price has surpassed its 200-day moving average of GBX 24.14, reaching a high of GBX 30.10 during trading.
• The company has a market cap of £131.56 million and operates globally, focusing on diagnostics in hematology and diabetes.
• EKF maintains a debt-to-equity ratio of 0.34 and a current ratio of 4.60, indicating a stable financial position.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 24.14 ($0.32) and traded as high as GBX 30.10 ($0.40). EKF Diagnostics shares last traded at GBX 29.50 ($0.40), with a volume of 525,589 shares trading hands.

EKF Diagnostics Stock Performance

The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34. The company's 50-day simple moving average is GBX 27.08 and its 200-day simple moving average is GBX 24.17. The stock has a market capitalization of £130.12 million, a price-to-earnings ratio of 27.24 and a beta of 0.57.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.